Technical Deep Dive: Validating Vacuum Decay CCI Testing for 2 mL & 10 mL Vials
Technical Deep Dive: Validating Vacuum Decay CCI Testing for 2 mL & 10 mL Vials We’re pleased to share a […]
Placebo Tablet Manufacturing: A Critical Foundation for Robust IMP Trials
Placebos are more than “inactive tablets.” In clinical research, a well-designed and manufactured placebo is a strategic tool that directly
Encapsulation & Over-Encapsulation: Why They Matter for High-Quality IMP Trials
In clinical research, the manufacture and presentation of investigational medicinal products (IMPs) are as critical as the study design itself.
The challenges of blinding in clinical trial – and how we make it easier and more effective
Blinding is an essential ingredient in a randomised controlled trial (RCT), ensuring that the placebo and the Investigational Medicinal Product
Bridging the gap between chemistry, manufacturing, and control (CMC) data and the regulator, for right first time trial approval
The quicker your clinical trial can be approved by the regulator, the quicker you can progress your study and proceed
Trial medication about to expire? Here are the options
Investigational Medicinal Products (IMPs) that expire before last patient, last visit are undoubtedly a nightmare scenario for any Sponsor. In
Succeed faster to get early-phase studies through milestones quicker
We’ve posted elsewhere about the many data challenges involved in early-phase clinical trial approval, and how we at Eramol adopt
The challenges of QP and IMP changes: let us guide you
Brexit was always going to bring upheaval to our industry, and at the end of the United Kingdom’s transition period,